Header cover image

Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech High Insider Buying

Hong Kong Pharmaceuticals & Biotech High Insider Buying

Results

15

1 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

15 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1093 CSPC Pharmaceutical Group	HK$5.19	0%	-26.4%	HK$60.7b	HK$7.35	PE10.9x	E2.7%	6.2%
	867 China Medical System Holdings	HK$7.65	-0.5%	-46.1%	HK$18.6b	HK$10.87	PE12.4x	E21.4%	5.5%
	1530 3SBio	HK$5.69	-2.4%	-23.1%	HK$13.8b	HK$7.97	PE7.5x	E14.6%	4.3%
	6185 CanSino Biologics	HK$29.15	-3.0%	5.6%	HK$12.3b	HK$29.92	PS9x	E141.4%	0%
	2005 SSY Group	HK$3.81	-1.3%	-23.3%	HK$11.6b	HK$6.16	PE8.3x	E5.8%	4.7%
	1681 Consun Pharmaceutical Group	HK$8.45	-0.7%	82.1%	HK$7.0b	HK$9.34	PE7.8x	E14.9%	6.9%
	3613 Beijing Tong Ren Tang Chinese Medicine	HK$8.05	0.6%	-38.2%	HK$6.8b	HK$12.05	PE13.6x	E16.5%	4.1%
	775 New CK Life Sciences Int'l. (Holdings)	HK$0.46	1.1%	-31.3%	HK$4.4b	n/a	PS0.8x	n/a	0%
	2487 Cutia Therapeutics	HK$8.30	-13.5%	-58.4%	HK$2.6b	HK$14.72	PS11.9x	E49.4%	n/a
	2616 CStone Pharmaceuticals	HK$1.99	9.9%	-20.1%	HK$2.5b	HK$2.51	PS5.2x	E49.9%	n/a
	950 Lee's Pharmaceutical Holdings	HK$1.23	-3.9%	-7.5%	HK$724.3m	n/a	PE11.5x	n/a	2.4%
	1244 3D Medicines	HK$2.02	-6.0%	-77.0%	HK$519.5m	n/a	PS0.9x	n/a	n/a
	9939 Kintor Pharmaceutical	HK$1.08	-6.1%	-67.1%	HK$471.9m	HK$14.15	PB1.1x	E25.8%	n/a
	6628 Transcenta Holding	HK$0.77	-13.5%	-78.6%	HK$315.9m	HK$8.77	PS13x	E12.7%	n/a
	2257 Sirnaomics	HK$2.80	2.6%	-94.1%	HK$225.7m	HK$72.10	PS29x	S63.5%	n/a

Page 1 of 1